Rossiello M R, Laconi E, Rao P M, Rajalakshmi S, Sarma D S
Department of Pathology, University of Toronto, Ontario, Canada.
Cancer Lett. 1993 Jul 30;71(1-3):83-7. doi: 10.1016/0304-3835(93)90101-e.
Aristolochic acid (AA), used as an anti-inflammatory agent in the past, is known to be mutagenic and carcinogenic to several organs of the rat, including forestomach, renal pelvis and urinary bladder. However, despite the induction of DNA adducts in the liver, no carcinogenic potential of AA has been reported in the latter organ. The present study was based on the rationale that the lack of carcinogenicity of AA to the liver could be because this chemical may not be necrogenic at the doses examined and liver cell proliferation has been established as an essential component for initiation of liver carcinogenesis in the rat. The results indicated that AA is non-necrogenic to the rat liver. However, a single non-necrogenic dose of AA (10 mg/kg b.w., i.p.) given 18 hours after 2/3 partial hepatectomy initiated liver cell carcinogenesis. The initiated cells are promotable with 1% dietary orotic acid, a liver tumor promoter, to form glutathione-S-transferase 7-7 positive hepatic foci and nodules.
马兜铃酸(AA)过去曾用作抗炎剂,已知对大鼠的多个器官具有致突变性和致癌性,包括前胃、肾盂和膀胱。然而,尽管在肝脏中诱导了DNA加合物,但尚未有关于AA在该器官致癌潜力的报道。本研究基于这样的理论基础:AA对肝脏缺乏致癌性可能是因为在检测剂量下这种化学物质不会引起坏死,并且肝细胞增殖已被确认为大鼠肝癌发生起始的一个重要组成部分。结果表明,AA对大鼠肝脏无致坏死作用。然而,在2/3部分肝切除术后18小时给予单一非致死剂量的AA(10毫克/千克体重,腹腔注射)可引发肝细胞癌变。起始细胞可被1%的膳食乳清酸(一种肝脏肿瘤促进剂)促进,形成谷胱甘肽-S-转移酶7-7阳性肝灶和结节。